| |
| |
|
| Insider
Information: |
Ferra Joseph J Jr |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
172,680 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$763,326 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
172,680 |
|
|
| Total
Value |
$763,326 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Syros Pharmaceuticals, Inc. |
SYRS |
Chief Financial Officer |
2019-02-12 |
87,000 |
2019-02-12 |
0 |
Premium* |
|
|
Elevation Oncology, Inc. |
ELEV |
|
2024-03-16 |
85,680 |
2022-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELEV |
Elevation Oncology, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-16 |
4 |
D |
$4.39 |
$20,953 |
D/D |
(4,773) |
85,680 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,562 |
90,453 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-12-16 |
4 |
D |
$0.51 |
$2,434 |
D/D |
(4,773) |
77,891 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,563 |
82,664 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-09-16 |
4 |
D |
$0.73 |
$3,475 |
D/D |
(4,773) |
70,101 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-09-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,562 |
74,874 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
INTERIM CEO & CFO |
• – – |
2023-06-16 |
4 |
D |
$1.47 |
$7,016 |
D/D |
(4,773) |
62,312 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
INTERIM CEO & CFO |
• – – |
2023-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,563 |
67,085 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
INTERIM CEO & CFO |
• – – |
2023-03-16 |
4 |
D |
$2.35 |
$11,217 |
D/D |
(4,773) |
54,522 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
INTERIM CEO & CFO |
• – – |
2023-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,563 |
59,295 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-12-16 |
4 |
D |
$0.95 |
$4,534 |
D/D |
(4,773) |
46,732 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,562 |
51,505 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-09-16 |
4 |
D |
$1.25 |
$5,966 |
D/D |
(4,773) |
38,943 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-09-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,562 |
43,716 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-06-16 |
4 |
D |
$1.26 |
$24,060 |
D/D |
(19,095) |
31,154 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,249 |
50,249 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
87,000 |
87,000 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
